CAFC

21-2024

Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc.

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

Filed06/08/21

Appeal FromD. Nevada

Originating Case2:16-cv-02525

Decision02/15/22

Appeal OutcomeAppellee

Judges

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Judge	Cases	PO Affirm Rate	Ch Affirm Rate
Pauline Newman	500+	50%	50%
Timothy B. Dyk	500+	50%	50%
Jimmie V. Reyna	500+	50%	50%

Appellant

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Epa Drug Initiative II	-- -- --

No Parties

Attorney

Name	Ratings
Michael S Kasanoff	L5 A
Patrick J. Coyne	L5 A

No Attorneys

Appellee

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Hikma Pharmaceuticals USA Inc	-- -- --
Hikma Pharmaceuticals Intl Ltd	-- -- --
DR Reddys Laboratories Ltd	-- -- --
DR Reddys Laboratories Inc	-- -- --
West-Ward Pharmaceuticals Intl Ltd	-- -- --

No Parties

Attorney

Name	Ratings
Windels Marx Lane Mittendorf	L5 A
Patrick J. Coyne	L5 A
Scott E. Holwick	L5 A
Robert D. Bajefsky	L5 A
Aaron M. Raphael	L5 A
Winston & Strawn LLP	L5 A
Neal S. Cohen	L5 A
Peter Kinsella	L5 A
Scott J. Popma	L5 A
Jennifer S. Swan	L5 A

No Attorneys